Euvichol-S | Cholera

Context (FE): WHO prequalifies new oral vaccine for cholera, Euvichol-S.
The new vaccine is the third product of the same family of vaccines for cholera in the WHO prequalification list, Euvichol and Euvichol-Plus.
Euvichol-S is a simplified formulation of the oral cholera vaccine (OCV) Euvichol-Plus.
The vaccine is manufactured by South Korea-based EuBiologics Co., Ltd. (EuBiologics is the largest supplier of oral cholera vaccine in the world, representing more than 80% market share).

Cholera

Cholera is an acute, diarrheal illness caused by infection of the intestine with the toxigenic bacterium Vibrio cholerae.
The cholera bacterium is usually found in water or in foods that have been contaminated by feces from a person infected with cholera bacteria.
Spread: It is most likely to occur and spread in places with inadequate water treatment, poor sanitation, and inadequate hygiene.
Symptoms: Rapid heart rate, loss of skin elasticity (the ability to return to original position quickly if pinched), dry mucous membranes, low blood pressure, thirst, muscle cramps.